January 2026

12 January 2026

Apply Online for Senior Clinical Research Associate at Takeda

Evaluate the quality and integrity of study site practices related to the proper conduct of the protocol and adherence to applicable regulations. Escalate quality issues as appropriate.

12 January 2026

Work as Trials and Publication Project Manager at AstraZeneca

Works in close collaboration with the external service provider and Investigators to ensure quality and quantity commitments are achieved in a timely and efficient manner.

12 January 2026

Regulatory Professional Wanted at Novo Nordisk - BPharm, MPharm Apply

Managing initial clinical trial application submissions in the EU according to the Clinical Trial Regulation and all changes during the life cycle of clinical trials.

12 January 2026

TCS Hiring Clinical Data Reviewer

Preparing eCRF specifications, Edit check specification and other study specific set up documents.

12 January 2026

Openings in Quality Control and Manufacturing (Nasal) at Dr. Reddy’s

Should be well-versed with techniques such as Spraytech, and Sprayview8t Pattern, Pump delivery test also good working knowledge of HPLC.

12 January 2026

Teva looking for Regulatory Coordinator

Regulatory Coordinator will support the Director, Regulatory Affairs and other Senior Directors in International Markets to organize and perform required tasks for regulatory affairs in order to maintain compliance with current regulations and in-house standards.

12 January 2026

Bristol Myers Squibb Require Safety Data Sheet Specialist Writer

Bachelors degree in chemistry, toxicology, product stewardship, industrial hygiene or related discipline required

12 January 2026

Career opportunities with V-Ensure Pharma Technologies for Pharmacy candidates

Handling of production machines such as BQS, Coating, Granulation. Bottle line packing machine primary and secondary.

12 January 2026

CuraTeQ Biologics gets Health Canada NOC for Pegylated Filgrastim Biosimilar Dyrupeg

CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Ltd, has received a Notice of Compliance (NOC) from Health Canada’s Biologics and Radiopharmaceutical Drugs Directorate (BRDD) for Dyrupeg™, its pegylated filgrastim biosimilar.

12 January 2026

Biocon Pharma Secures USFDA Approval for Everolimus Tablets for Oral Suspension

Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Everolimus Tablets for Oral Suspension. The approval covers 2 mg, 3 mg and 5 mg strengths.